PINP as a biological response marker during teriparatide treatment for osteoporosis

John H. Krege(Eli Lilly (United States)), Paul D. Miller(University of North Carolina at Chapel Hill), Nancy E. Lane(University of California, Davis), Jennifer Harris(Boston Medical Center)
Osteoporosis International
March 5, 2014
Cited by 164


Related Papers